Literature DB >> 11099766

Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice.

D Van Dam1, R D'Hooge, E Hauben, E Reyniers, I Gantois, C E Bakker, B A Oostra, R F Kooy, P P De Deyn.   

Abstract

Fmr1 knockout mice are an animal model for fragile X syndrome, the most common form of heritable mental retardation in humans. Fmr1 knockout mice exhibit macro-orchidism and cognitive and behavioural deficits reminiscent of the human phenotype. In the present study additional behavioural and cognitive testing was performed. Knockouts and control littermates were subjected to a spatial learning test using a plus-shaped water maze. Animals had to learn the position of a hidden escape platform during training trials. The position of this platform was changed during subsequent reversal trials. Previously reported deficits in reversal learning were replicated, but we also observed significant differences during the acquisition trials. A plus-shaped water maze experiment with daily changing platform positions failed to provide clear evidence for a working memory impairment, putatively underlying the spatial learning deficits. Two different test settings were used to examine the reported deficit of Fmr1 knockout mice in fear conditioning. Conditioned fear responses were observed in a contextual fear test, and the ability to acquire an emotional response was tested by means of response suppression in a conditioned emotional response procedure. Neither protocol revealed significant differences between controls and knockouts.

Entities:  

Mesh:

Year:  2000        PMID: 11099766     DOI: 10.1016/s0166-4328(00)00296-5

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  46 in total

1.  Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning.

Authors:  Weixiang Guo; Andrea M Allan; Ruiting Zong; Li Zhang; Eric B Johnson; Eric G Schaller; Adeline C Murthy; Samantha L Goggin; Amelia J Eisch; Ben A Oostra; David L Nelson; Peng Jin; Xinyu Zhao
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

Review 2.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

3.  The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Authors:  Jose Luis Olmos-Serrano; Joshua G Corbin; Mark P Burns
Journal:  Dev Neurosci       Date:  2011-11-08       Impact factor: 2.984

4.  Olfactory discrimination learning in mice lacking the fragile X mental retardation protein.

Authors:  John Larson; Daniel Kim; Roseanne C Patel; Christina Floreani
Journal:  Neurobiol Learn Mem       Date:  2008-03-04       Impact factor: 2.877

Review 5.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

Review 6.  Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.

Authors:  Justin W Kenney; Thomas J Gould
Journal:  Mol Neurobiol       Date:  2008-08-09       Impact factor: 5.590

Review 7.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

8.  Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome.

Authors:  Hailan Hu; Yi Qin; Genrieta Bochorishvili; Yinghua Zhu; Linda van Aelst; J Julius Zhu
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

Review 9.  The role of ARID1B, a BAF chromatin remodeling complex subunit, in neural development and behavior.

Authors:  Jeffrey J Moffat; Eui-Man Jung; Minhan Ka; Amanda L Smith; Byeong Tak Jeon; Gijs W E Santen; Woo-Yang Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-08-24       Impact factor: 5.067

Review 10.  Potential pharmacological treatment of fragile X syndrome during adulthood.

Authors:  Zhao-Hui Xu; Ming-Gao Zhao
Journal:  Neurosci Bull       Date:  2009-10       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.